This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma S.a.. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovations of Jean-Marie Stutzman
Introduction
Jean-Marie Stutzman is a notable inventor based in Villecresnes, France. He has made significant contributions to the field of medicine, particularly in the treatment of cerebral edemas. His innovative approach has led to the development of a patent that addresses a critical health issue.
Latest Patents
Stutzman holds a patent for the "Use of low-molecular-weight heparins for the prevention and treatment of cerebral edemas." This patent highlights the effectiveness of administering low molecular weight heparin to prevent and treat cerebral edema, a condition that can have serious implications for patients.
Career Highlights
Stutzman is associated with Aventis Pharma S.A., a prominent pharmaceutical company. His work there has focused on advancing medical treatments and improving patient outcomes through innovative solutions.
Collaborations
Throughout his career, Stutzman has collaborated with esteemed colleagues, including Florence Wahl and Véronique Mary. These partnerships have contributed to the success of his research and the development of his patent.
Conclusion
Jean-Marie Stutzman is a distinguished inventor whose work in the medical field has led to important advancements in the treatment of cerebral edemas. His contributions continue to impact patient care positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile